Navigation Links
Low vitamin D linked to higher risk of hip fracture
Date:9/20/2007

HONOLULU, Sept. 20 Women with low levels of vitamin D have an increased risk of hip fracture, according to a study led by the University of Pittsburgh Graduate School of Public Health presented this week at the 29th annual meeting of the American Society for Bone and Mineral Research at the Hawaii Convention Center.

Jane A. Cauley, Dr.P.H., professor of epidemiology, and colleagues evaluated patient data on 400 women enrolled in the Womens Health Initiative Observational Study Cohort who had experienced hip fracture, confirmed by their medical record, over a median of 7.1 years. Levels of 25 hydroxyvitamin D, an indicator of vitamin D status, in the bloodstream were measured for these patients and compared with those of a control group matched for age, race, ethnicity and the date of relevant blood work. As vitamin D concentrations decreased, the risk of hip fractures climbed.

The risk of hip fractures was 77 percent higher among women whose 25 hydroxyvitamin D levels were at the lowest concentrations, said Dr. Cauley, who has spent much of the past 15 years investigating the physical changes that take place in postmenopausal women. This effect persisted even when we adjusted for other risk factors such as body mass index, family history of hip fracture, smoking, alcohol use and calcium and vitamin D intake.

Vitamin D deficiency early in life is associated with rickets a disorder characterized by soft bones and thought to have been eradicated in the United States more than 50 years ago.

Though the exact daily requirement of vitamin D has not been determined, most experts think that people need at least 800 to 1,000 international units a day. Many experts believe the current recommended levels of 400 IUs daily should be increased.

The vitamin is manufactured in the skin after sun exposure, and is not available naturally in many foods other than fish liver oils. Some foods are fortified with the vitamin.


'/>"/>

Contact: Michele Baum
BaumMD@upmc.edu
412-647-3555
University of Pittsburgh Schools of the Health Sciences
Source:Eurekalert

Page: 1 2

Related biology news :

1. Does vitamin C help prevent or treat the common cold? Maybe not, after all.
2. Vitamin As paradoxical role in influencing symmetry during embryonic development revealed
3. OHSU research shows vitamin C counteracts some negative impacts of smoking on unborn babies
4. Vitamin D deficiency widespread during pregnancy
5. Natural vitamin E tocotrienol reaches blood at protective levels
6. Poor athletic performance linked to vitamin deficiency
7. MIT biologists solve vitamin puzzle
8. Cocoa vitamin health benefits could outshine penicillin
9. Misusing vitamin to foil drug test may be toxic; plus, it doesnt work
10. Vitamins: Science doesnt always match policy
11. Fat overrides effects of vitamin C

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/5/2009)...ssociation of Biology Teachers (NABT) will recogni...ciences at Naugatuck Valley Community College (NVC...ion Education Award during the NABT annual profess...mber 2009 in Denver, Colorado. , The Evolution E...itute of Biological Sciences,(AIBS) and Biologica...
(Date:11/5/2009)...versity has been awarded a training grant in the a...tion under its Integrative Graduation Education an...irst IGERT grant to be awarded to Kent State. The ... and Reinvestment Act of 2009, runs through 2014. ...on environment aquatic resource sensing (EARS). Th...
(Date:11/4/2009)... news in natural science) , United States Usin...s water today than it did 35 years ago, despite a ...use are partly attributable to alternative cooling...tion systems. According to the latest USGS water u...ited States goes to cooling thermoelectric power p...
Breaking Biology News(10 mins):Biologists, educators recognize excellence in evolution education 2Kent State receives $2.7 million NSF training grant for environmental aquatic resource sensing 2USGS science picks 2USGS science picks 3USGS science picks 4USGS science picks 5USGS science picks 6USGS science picks 7Roux en Y weight loss surgery raises kidney stone risk 49271 1Roux en Y weight loss surgery raises kidney stone risk 49271 2Valensa Selects Parry Organic Spirulina as Ingredient of Choice for Premium Product Development 49269 1Valensa Selects Parry Organic Spirulina as Ingredient of Choice for Premium Product Development 49269 2Valensa Selects Parry Organic Spirulina as Ingredient of Choice for Premium Product Development 49269 3Valensa Selects Parry Organic Spirulina as Ingredient of Choice for Premium Product Development 49269 4Taking Aim at Relapse of Leukemia in Kids 49267 1Taking Aim at Relapse of Leukemia in Kids 49267 2
...r deterioration seen in muscular dystrophy can be ...y for their effects against cancer, a Burnham Inst... the potential use of these drugs, called histone ...and repair of dystrophic muscles, thereby counteri...t mouse models of muscular dystrophy. Led by Burnh...
...new project being developed by Central Queensland ... surgery patients around the country could soon ha...t of their own home rather than having to travel t... University’s Rockhampton campus are developing an...ple who have had heart surgery to see if it improv...
...technical advance in the study of the complex rece...researchers at the University of California, San D...the signaling pathways that impact activation of a...ing and to the thrombosis that occurs in heart att...re-build the signaling pathway that regulates acti...
Other Biology News:Experimental cancer drugs counter muscle deterioration seen in muscular dystrophy 2UCSD researchers create roadmap to integrin activation 2UCSD researchers create roadmap to integrin activation 3
(Date:11/6/2009)... Intarcia Therapeutics, Inc. deliv...S® continuous delivery of exenatide) program ...Annual Diabetes Technology Meeting in San Francisc...n/prnh/20050301/SFTU126LOGO ) ,, Continuous S...ers Plasma Glucose, HbA1c and Reduces Weight in a ...
(Date:11/5/2009)... 5 GenVec, Inc. (Nasdaq:... the third quarter ended September 30, 2009. GenVe...hare) for the three months ended September 30, 200...r share) in the comparable quarter of 2008. For th...et loss was $14.1 million ($0.15 per share), compa...
(Date:11/5/2009)...wswire-FirstCall/ -- Imagenetix, Inc. (OTC Bulleti...er, President and CEO of Imagenetix, will be prese...RO Conference on Thursday, December 3rd, at 10:30 ...out LD MICRO ,, LD MICRO is a by-invitation onl...ued companies in the micro-cap space. Since 2002, ...
(Date:11/5/2009)...Newswire-FirstCall/ -- Transgenomic, Inc. (OTC Bul...ts for the quarter ended September 30, 2009. The C...bles that follow. ,, Third Quarter 2009 ,,....01 per share for the third quarter of 2009 as com... for the third quarter of 2008. ,, Net sales w...
Breaking Biology Technology:Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 4Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 5GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6Imagenetix to Present at 2nd Annual LD MICRO Conference at the Luxe Sunset Bel Air 2Transgenomic, Inc. Reports Third Quarter 2009 Results 2Transgenomic, Inc. Reports Third Quarter 2009 Results 3Transgenomic, Inc. Reports Third Quarter 2009 Results 4Transgenomic, Inc. Reports Third Quarter 2009 Results 5Transgenomic, Inc. Reports Third Quarter 2009 Results 6Transgenomic, Inc. Reports Third Quarter 2009 Results 7
...harmaceuticals,a division of Wyeth (NYSE: WYE ), ...ments with Solvay Pharmaceuticals for the developm... other compounds in earlier,stages of development ...ther psychiatric conditions., Wyeth terminated th...portunity for bifeprunox and determining it would ...
...ng distributor of market,intelligence, MarketResea...hip with Spectra Intelligence which allows for the...ry market analyses through the,MarketResearch.com ...ofessionals throughout the world,easy access to co... from,research publications authored by market exp...
...ex, Inc.,(Nasdaq: MEDX ) announced today that it ...al Group Second Annual SIGnificant Investment Opti...dnesday, March 5, 2008, in New,York. The event wil...estor,Relations section of the Medarex website at ...he presentation will be available following the ev...
Other Biology Technology:Wyeth Pharmaceuticals Ends Collaboration Agreements with Solvay Pharmaceuticals for Bifeprunox and Other Compounds 2MarketResearch.com Announces Distribution of Spectra Intelligence Research 2Medarex to Present at the Susquehanna Financial Group Healthcare Conference 2
BMP-2 ELISA Kit from R&D Systems
5x MONO-RABBIT POLY C'GATE DILUENT from AbD Serotec
Argarase from BioVision
SAMPLE DILUENTS BUFFER TRIAL PACK from AbD Serotec
Biology Products: